Minapharm has made its mission to provide patients in developing countries with easy access to innovative and high-quality medicines. Minapharm’s expertise encompasses a wide range of medicines, from small molecules with advanced galenic formulation to more complex bioengineered proteins.
Learn MoreMinapharm develops, manufactures and commercializes over 150 life-saving and life-enhancing products, ranging from small molecules to complex genetically engineered proteins. The company also offers an impressive portfolio of proprietary technologies used by the global biotech industry at large.
Mianpharm is the only gene-to-market company in Africa and the Middle East providing advanced proprietary technologies to the global biotech industry coupled with end-to-end manufacturing and commercialization expertise for many decades.
Minapharm takes a regional approach to affecting global change. Together with its global subsidiary MiGenTra GmbH, Minapharm has a core mission to satisfy the unmet medical needs of patients in Africa and the Middle East.